Rigel Pharmaceuticals
RIGL
#6899
Rank
NZ$1.20 B
Marketcap
NZ$65.21
Share price
-3.45%
Change (1 day)
99.72%
Change (1 year)

Earnings for Rigel Pharmaceuticals (RIGL)

Earnings in 2026 (TTM): NZ$0.21 Billion

According to Rigel Pharmaceuticals's latest financial reports the company's current earnings are NZ$0.29 Billion. In 2025 the company made an earning of NZ$0.22 Billion, an increase over its 2024 earnings that were of NZ$45.15 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Rigel Pharmaceuticals from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$0.21 B-2.04%
2025 NZ$0.22 B391.35%
2024 NZ$45.15 M-244.27%
2023 -NZ$31.31 Million-66.79%
2022 -NZ$94.26 Million340.73%
2021 -NZ$21.39 Million-56.15%
2020 -NZ$48.78 Million-57.34%
2019 -NZ$0.12 Billion-7.66%
2018 -NZ$0.13 Billion-9.47%
2017 -NZ$0.14 Billion24.46%
2016 -NZ$0.11 Billion23.63%
2015 -NZ$88.9 Million-43.29%
2014 -NZ$0.16 Billion2.5%
2013 -NZ$0.16 Billion
2010 NZ$65.04 M-133.97%
2009 -NZ$0.2 Billion-18.49%
2008 -NZ$0.24 Billion71.91%
2007 -NZ$0.14 Billion84.74%
2006 -NZ$73.96 Million-10.17%
2005 -NZ$82.33 Million-15.73%
2004 -NZ$97.7 Million39.29%
2003 -NZ$70.15 Million10.3%
2002 -NZ$63.6 Million48.3%
2001 -NZ$42.89 Million-2.13%
2000 -NZ$43.82 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
NZ$15.61 B 6,951.13%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$25.19 B 11,278.64%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sangamo Therapeutics
SGMO
-NZ$0.19 Billion-185.61%๐Ÿ‡บ๐Ÿ‡ธ USA
ChemoCentryx
CCXI.defunct
-NZ$0.23 Billion-201.34%๐Ÿ‡บ๐Ÿ‡ธ USA